National Health (Pharmaceutical Benefits Early Supply) Amendment Instrument 2015 (No. 6) specification under subsection 84AAA(2) (PB 71 of 2015) (Cth)

PB 71 of 2015

National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 6) – specification under subsection 84AAA(2)

National Health Act 1953

I, KYLIE JONASSON, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 27 July 2015

KYLIE JONASSON
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health

___________________________________________________________________________

Amendment determination – Pharmaceutical Benefits – Early Supply

1          Name of Instrument

(1)      This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 6) – specification under subsection 84AAA(2).

(2)This Instrument may also be cited as PB 71 of 2015.

2          Commencement

This Instrument commences on 1 August 2015.

3          Amendment of PB 30 of 2009

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).

Schedule 1        Amendments

1. Schedule 1, entry for Adalimumab

   insert as first item in the columns in the order indicated:

Injection 20 mg in 0.4 mL pre-filled pen Injection 2 5

1. Schedule 1, after entry for Ezetemibe and rosuvastatin

   insert:

Ezetimibe with atorvastatin	Tablet 10 mg-10 mg	Oral	30	5
Tablet 10 mg-20 mg	Oral	30	5
Tablet 10 mg-40 mg	Oral	30	5
Tablet 10 mg-80 mg	Oral	30	5

1. Schedule 1, after entry for Testosterone in the form Capsule containing testosterone undecanoate 40 mg

   insert in the columns in the order indicated:

Transdermal cream 50 mg per mL, 50 mL Transdermal 1 6